Avotermin: Clinical Trials

15 trials of Avotermin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 2 unknown, 1 terminated, 1 withdrawn. 13 Phase 2, 6 Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 213Completed 10, Unknown 2, Terminated 1
Phase 16Completed 6
Not applicable1Withdrawn 1

Follow Avotermin: new trials by email Literature Review of Avotermin trials Research Report on Avotermin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Juvista in the Non-surgical Improvement of Existing Scars
Juvista, Placebo - Scars
Not applicableWithdrawnRenovo402009-01-012010-03-09
Safety of Juvista When Administered Following Excision of Ear Lobe Keloids
Avotermin, placebo - Keloid
Phase 1 / Phase 2CompletedRenovo102008-07-012010-03-09
Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars
Avotermin - Keloid
Phase 1 / Phase 2CompletedRenovo202007-06-012009-09-16
Juvista (Avotermin) in Scars Following Varicose Vein Removal
Avotermin - Varicose Veins, Cicatrix
Phase 2CompletedRenovo1562006-11-012010-03-09
Juvista (Avotermin) in Breast Reduction Surgery Scars
Avotermin - Mammaplasty, Cicatrix
Phase 2TerminatedRenovo392006-10-012009-01-13
Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions
Avotermin, Placebo - Cicatrix
Phase 2CompletedRenovo392006-07-012008-03-04
Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.
Avotermin - Cicatrix
Phase 2UnknownRenovo602006-05-012009-02-04
RN1001(Avotermin) in Scar Improvement Following Breast Augmentation
Avotermin - Mammaplasty, Cicatrix
Phase 2CompletedRenovo632004-12-012008-08-14
A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision
Avotermin - Nevus, Cicatrix
Phase 2UnknownRenovo2392004-04-012008-04-11
Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males
Juvista (avotermin) plus placebo, standard-care (within-subject controls) - Cicatrix
Phase 2CompletedRenovo712003-10-012008-01-15
Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites
Avotermin, Placebo - Cicatrix, Wound Healing
Phase 2CompletedRenovo1022003-10-012009-09-25
Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects
Avotermin, Placebo - Cicatrix, Wound Healing
Phase 1 / Phase 2CompletedRenovo352003-04-012009-09-25
Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.
Avotermin, Placebo - Cicatrix
Phase 1 / Phase 2CompletedRenovo422002-09-012009-02-19
Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista)
Avotermin, Placebo - Cicatrix, Wound Healing
Phase 1 / Phase 2CompletedRenovo432002-02-012009-09-16
Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)
Avotermin, Placebo (vehicle) - Cicatrix, Wound Healing
Phase 1CompletedRenovo552001-05-012009-09-16

Conditions studied

Cicatrix (13)  ·  Arrhythmogenic Right Ventricular Dysplasia, Familial, 1 (2)  ·  Keloid (2)  ·  Nevus (1)  ·  Varicose Veins (1)

Sponsors

Renovo (15)

Countries

United Kingdom (13)  ·  United States (2)  ·  Belgium (1)  ·  Latvia (1)  ·  Lithuania (1)

Top investigators

Jonathan Duncan (3)  ·  Jeremy Bond (2)  ·  Michael J Davies (2)  ·  D A McGrouther, FRCS MD (1)  ·  David Whitby (1)  ·  James Bush (1)  ·  James Bush, MBChB (1)  ·  James Dr Bush, MBChB MRCS (1)  ·  Jim Bush, MB ChB (1)  ·  Jim Bush, MBChB (1)  ·  Jonathan Duncan, BS BCh (1)  ·  Leroy Young, MD (1)  ·  Peter McCollum, MB MCh FRCS (1)  ·  Philip Gilbert, FDSRCS FRCS (1)  ·  V V Young, MD (1)

Results publications

PMID 19362676, PMID 21042116, PMID 21618480, PMID 21701333